TNF-α Downregulation Modifies Insulin Receptor Substrate 1 (IRS-1) in Metabolic Signaling of Diabetic Insulin-Resistant Hepatocytes

One of the major mechanisms of hyperglycemia in type 2 diabetes is insulin resistance (IR) which can induce free fatty acids like palmitate. In hepatic cell, as an insulin target tissue, insulin resistance can be stimulated by inflammatory cytokine TNF-α. The interaction of intracellular TNF-α signa...

Full description

Saved in:
Bibliographic Details
Main Authors: Iraj Alipourfard, Nelly Datukishvili, Davit Mikeladze
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2019/3560819
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850230284582125568
author Iraj Alipourfard
Nelly Datukishvili
Davit Mikeladze
author_facet Iraj Alipourfard
Nelly Datukishvili
Davit Mikeladze
author_sort Iraj Alipourfard
collection DOAJ
description One of the major mechanisms of hyperglycemia in type 2 diabetes is insulin resistance (IR) which can induce free fatty acids like palmitate. In hepatic cell, as an insulin target tissue, insulin resistance can be stimulated by inflammatory cytokine TNF-α. The interaction of intracellular TNF-α signal with the insulin signaling pathway is not well identified. Hence, we aimed to investigate the effect of TNF-α elimination on the diabetic model of palmitate-induced insulin-resistant hepatocytes (HepG2). The changes of phosphorylation rate in IRS-1 protein are determined to know the effect of TNF-α on this key protein of the insulin signaling pathway. HepG2 cells were treated with 0.5 Mm palmitate, and TNF-α gene knockdown was performed by shRNA-mediated technique. Western blot analysis was used to evaluate the phosphorylated activity of the insulin signaling pathway. Palmitate-induced IR could increase TNF-α protein expression 1.2-, 2.78-, and 2.25-fold compared to the control cells at times of 8 h, 16 h, and 24 h, respectively. TNF-α expression in downregulated cells transfected with shRNA-TNF-α is approximately 47.0% of normal cells and 49.0% in the case of scrambled cells. IRS-1 phosphorylation in TNF-α-downregulated and stimulated cells with 100 nM insulin, after treatment and in the absence of palmitate, was 45% and 29% higher than the normal cells. These data support the evidence that TNF-α downregulation strategy contributes to the improvement of IRS-1 phosphorylation after insulin stimulation and insulin response in HepG2 liver cells.
format Article
id doaj-art-209a2220c8184c4982c95fbef32dc6be
institution OA Journals
issn 0962-9351
1466-1861
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-209a2220c8184c4982c95fbef32dc6be2025-08-20T02:03:55ZengWileyMediators of Inflammation0962-93511466-18612019-01-01201910.1155/2019/35608193560819TNF-α Downregulation Modifies Insulin Receptor Substrate 1 (IRS-1) in Metabolic Signaling of Diabetic Insulin-Resistant HepatocytesIraj Alipourfard0Nelly Datukishvili1Davit Mikeladze2Institute of Chemical Biology, School of Natural Sciences and Engineering, Ilia State University, Tbilisi 0162, GeorgiaInstitute of Chemical Biology, School of Natural Sciences and Engineering, Ilia State University, Tbilisi 0162, GeorgiaInstitute of Chemical Biology, School of Natural Sciences and Engineering, Ilia State University, Tbilisi 0162, GeorgiaOne of the major mechanisms of hyperglycemia in type 2 diabetes is insulin resistance (IR) which can induce free fatty acids like palmitate. In hepatic cell, as an insulin target tissue, insulin resistance can be stimulated by inflammatory cytokine TNF-α. The interaction of intracellular TNF-α signal with the insulin signaling pathway is not well identified. Hence, we aimed to investigate the effect of TNF-α elimination on the diabetic model of palmitate-induced insulin-resistant hepatocytes (HepG2). The changes of phosphorylation rate in IRS-1 protein are determined to know the effect of TNF-α on this key protein of the insulin signaling pathway. HepG2 cells were treated with 0.5 Mm palmitate, and TNF-α gene knockdown was performed by shRNA-mediated technique. Western blot analysis was used to evaluate the phosphorylated activity of the insulin signaling pathway. Palmitate-induced IR could increase TNF-α protein expression 1.2-, 2.78-, and 2.25-fold compared to the control cells at times of 8 h, 16 h, and 24 h, respectively. TNF-α expression in downregulated cells transfected with shRNA-TNF-α is approximately 47.0% of normal cells and 49.0% in the case of scrambled cells. IRS-1 phosphorylation in TNF-α-downregulated and stimulated cells with 100 nM insulin, after treatment and in the absence of palmitate, was 45% and 29% higher than the normal cells. These data support the evidence that TNF-α downregulation strategy contributes to the improvement of IRS-1 phosphorylation after insulin stimulation and insulin response in HepG2 liver cells.http://dx.doi.org/10.1155/2019/3560819
spellingShingle Iraj Alipourfard
Nelly Datukishvili
Davit Mikeladze
TNF-α Downregulation Modifies Insulin Receptor Substrate 1 (IRS-1) in Metabolic Signaling of Diabetic Insulin-Resistant Hepatocytes
Mediators of Inflammation
title TNF-α Downregulation Modifies Insulin Receptor Substrate 1 (IRS-1) in Metabolic Signaling of Diabetic Insulin-Resistant Hepatocytes
title_full TNF-α Downregulation Modifies Insulin Receptor Substrate 1 (IRS-1) in Metabolic Signaling of Diabetic Insulin-Resistant Hepatocytes
title_fullStr TNF-α Downregulation Modifies Insulin Receptor Substrate 1 (IRS-1) in Metabolic Signaling of Diabetic Insulin-Resistant Hepatocytes
title_full_unstemmed TNF-α Downregulation Modifies Insulin Receptor Substrate 1 (IRS-1) in Metabolic Signaling of Diabetic Insulin-Resistant Hepatocytes
title_short TNF-α Downregulation Modifies Insulin Receptor Substrate 1 (IRS-1) in Metabolic Signaling of Diabetic Insulin-Resistant Hepatocytes
title_sort tnf α downregulation modifies insulin receptor substrate 1 irs 1 in metabolic signaling of diabetic insulin resistant hepatocytes
url http://dx.doi.org/10.1155/2019/3560819
work_keys_str_mv AT irajalipourfard tnfadownregulationmodifiesinsulinreceptorsubstrate1irs1inmetabolicsignalingofdiabeticinsulinresistanthepatocytes
AT nellydatukishvili tnfadownregulationmodifiesinsulinreceptorsubstrate1irs1inmetabolicsignalingofdiabeticinsulinresistanthepatocytes
AT davitmikeladze tnfadownregulationmodifiesinsulinreceptorsubstrate1irs1inmetabolicsignalingofdiabeticinsulinresistanthepatocytes